486 related articles for article (PubMed ID: 34289373)
1. Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts.
Rodriguez AB; Peske JD; Woods AN; Leick KM; Mauldin IS; Meneveau MO; Young SJ; Lindsay RS; Melssen MM; Cyranowski S; Parriott G; Conaway MR; Fu YX; Slingluff CL; Engelhard VH
Cell Rep; 2021 Jul; 36(3):109422. PubMed ID: 34289373
[TBL] [Abstract][Full Text] [Related]
2. Tertiary Lymphoid Structure-Associated B Cells Enhance CXCL13
Hu C; You W; Kong D; Huang Y; Lu J; Zhao M; Jin Y; Peng R; Hua D; Kuang DM; Chen Y
Gastroenterology; 2024 Jun; 166(6):1069-1084. PubMed ID: 38445519
[TBL] [Abstract][Full Text] [Related]
3. STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment.
Chelvanambi M; Fecek RJ; Taylor JL; Storkus WJ
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33526609
[TBL] [Abstract][Full Text] [Related]
4. Identification and Characterization of Tertiary Lymphoid Structures in Murine Melanoma.
Rodriguez AB; Peske JD; Engelhard VH
Methods Mol Biol; 2018; 1845():241-257. PubMed ID: 30141017
[TBL] [Abstract][Full Text] [Related]
5. Tertiary Lymphoid Structures as a Predictive Biomarker of Response to Cancer Immunotherapies.
Trüb M; Zippelius A
Front Immunol; 2021; 12():674565. PubMed ID: 34054861
[TBL] [Abstract][Full Text] [Related]
6. Inducible Tertiary Lymphoid Structures: Promise and Challenges for Translating a New Class of Immunotherapy.
Aoyama S; Nakagawa R; Mulé JJ; Mailloux AW
Front Immunol; 2021; 12():675538. PubMed ID: 34054863
[TBL] [Abstract][Full Text] [Related]
7. The Tumor Immune Landscape and Architecture of Tertiary Lymphoid Structures in Urothelial Cancer.
van Dijk N; Gil-Jimenez A; Silina K; van Montfoort ML; Einerhand S; Jonkman L; Voskuilen CS; Peters D; Sanders J; Lubeck Y; Broeks A; Hooijberg E; Vis DJ; van den Broek M; Wessels LFA; van Rhijn BWG; van der Heijden MS
Front Immunol; 2021; 12():793964. PubMed ID: 34987518
[TBL] [Abstract][Full Text] [Related]
8. Investigating Tumor-Associated Tertiary Lymphoid Structures in Murine Lung Adenocarcinoma.
Connolly KA; Nader M; Joshi N
Methods Mol Biol; 2018; 1845():259-273. PubMed ID: 30141018
[TBL] [Abstract][Full Text] [Related]
9. Insights into Tumor-Associated Tertiary Lymphoid Structures: Novel Targets for Antitumor Immunity and Cancer Immunotherapy.
Rodriguez AB; Engelhard VH
Cancer Immunol Res; 2020 Nov; 8(11):1338-1345. PubMed ID: 33139300
[TBL] [Abstract][Full Text] [Related]
10. Tertiary lymphoid structures in desmoplastic melanoma have increased lymphocyte density, lymphocyte proliferation, and immune cross talk with tumor when compared to non-desmoplastic melanomas.
Edmonds NL; Gradecki SE; Katyal P; Lynch KT; Stowman AM; Gru AA; Engelhard VH; Slingluff CL; Mauldin IS
Oncoimmunology; 2023; 12(1):2164476. PubMed ID: 36632563
[TBL] [Abstract][Full Text] [Related]
11. Tertiary Lymphoid Structures: Autoimmunity Goes Local.
Pipi E; Nayar S; Gardner DH; Colafrancesco S; Smith C; Barone F
Front Immunol; 2018; 9():1952. PubMed ID: 30258435
[TBL] [Abstract][Full Text] [Related]
12. TGF-β-mediated silencing of genomic organizer SATB1 promotes Tfh cell differentiation and formation of intra-tumoral tertiary lymphoid structures.
Chaurio RA; Anadon CM; Lee Costich T; Payne KK; Biswas S; Harro CM; Moran C; Ortiz AC; Cortina C; Rigolizzo KE; Sprenger KB; Mine JA; Innamarato P; Mandal G; Powers JJ; Martin A; Wang Z; Mehta S; Perez BA; Li R; Robinson J; Kroeger JL; Curiel TJ; Yu X; Rodriguez PC; Conejo-Garcia JR
Immunity; 2022 Jan; 55(1):115-128.e9. PubMed ID: 35021053
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Induction of Tertiary Lymphoid Structures in Cancer Through Stromal Remodeling.
Johansson-Percival A; Ganss R
Front Immunol; 2021; 12():674375. PubMed ID: 34122434
[TBL] [Abstract][Full Text] [Related]
14. Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy.
Tang H; Zhu M; Qiao J; Fu YX
Cell Mol Immunol; 2017 Oct; 14(10):809-818. PubMed ID: 28413217
[TBL] [Abstract][Full Text] [Related]
15. Tertiary lymphoid structures improve immunotherapy and survival in melanoma.
Cabrita R; Lauss M; Sanna A; Donia M; Skaarup Larsen M; Mitra S; Johansson I; Phung B; Harbst K; Vallon-Christersson J; van Schoiack A; Lövgren K; Warren S; Jirström K; Olsson H; Pietras K; Ingvar C; Isaksson K; Schadendorf D; Schmidt H; Bastholt L; Carneiro A; Wargo JA; Svane IM; Jönsson G
Nature; 2020 Jan; 577(7791):561-565. PubMed ID: 31942071
[TBL] [Abstract][Full Text] [Related]
16. Targeting Tertiary Lymphoid Structures for Tumor Immunotherapy.
Tang H; Qiu X; Timmerman C; Fu YX
Methods Mol Biol; 2018; 1845():275-286. PubMed ID: 30141019
[TBL] [Abstract][Full Text] [Related]
17. STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development.
Filderman JN; Appleman M; Chelvanambi M; Taylor JL; Storkus WJ
Front Immunol; 2021; 12():690105. PubMed ID: 34054879
[TBL] [Abstract][Full Text] [Related]
18. Tertiary Lymphoid Structures and B cells: Clinical impact and therapeutic modulation in cancer.
Sautès-Fridman C; Verneau J; Sun CM; Moreira M; Chen TW; Meylan M; Petitprez F; Fridman WH
Semin Immunol; 2020 Apr; 48():101406. PubMed ID: 33248905
[TBL] [Abstract][Full Text] [Related]
19. High Endothelial Venules: A Vascular Perspective on Tertiary Lymphoid Structures in Cancer.
Vella G; Guelfi S; Bergers G
Front Immunol; 2021; 12():736670. PubMed ID: 34484246
[TBL] [Abstract][Full Text] [Related]
20. Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy.
Groeneveld CS; Fontugne J; Cabel L; Bernard-Pierrot I; Radvanyi F; Allory Y; de Reyniès A
Eur J Cancer; 2021 May; 148():181-189. PubMed ID: 33743486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
